Literature DB >> 23639917

Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.

Allison L Naleway1, Rachel Gold, Samantha Kurosky, Karen Riedlinger, Michelle L Henninger, James D Nordin, Elyse O Kharbanda, Stephanie Irving, T Craig Cheetham, Natalie L McCarthy.   

Abstract

BACKGROUND: The need for research on the safety of vaccination during pregnancy is widely recognized. Large, population-based data systems like the Vaccine Safety Datalink (VSD) may be useful for this research, but identifying pregnancies using electronic medical record (EMR) and claims data can be challenging.
METHODS: We modified an existing data processing algorithm to identify pregnancies within seven of the ten VSD sites. We validated the algorithm by calculating the agreement in pregnancy outcome type, end date, and gestational age between the algorithm and manual medical record review. At each participating site, we randomly sampled 15 episodes within four outcome type strata (live births, spontaneous abortions, elective abortions, and other pregnancy outcomes) for a total of 60 episodes per site. We also developed and validated methods to link mothers to their infants in the electronic data.
RESULTS: We identified 595,929 pregnancy episodes ending in 2002 through 2006 among women 12 through 55 years of age. Of these pregnancies, 75% ended in live births, 12% in spontaneous abortions, and 9% in elective abortions. We were able to confirm a pregnancy within 28 days of the algorithm-estimated pregnancy start date for 99% of live births, 93% of spontaneous abortions, 92% of elective abortions, and 90% of other outcomes sampled. The agreement between the algorithm-identified and the abstractor-identified outcome date ranged from 70% (elective abortion) to 96% (live birth) depending on outcome type. When gestational age was available in the EMR, agreement ranged from 82% (other) to 98% (live birth) depending on outcome type. We confirmed 100% of the 350 sampled mother-infant linkages with manual medical record review.
CONCLUSIONS: The VSD algorithm accurately identifies pregnancy episodes and mother-infant pairs across participating sites. Additional manual record review may be needed to improve the precision of the pregnancy date estimates depending on specific study needs. These algorithms will allow us to conduct large, population-based studies of the safety of vaccination during pregnancy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23639917     DOI: 10.1016/j.vaccine.2013.03.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  26 in total

1.  Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy.

Authors:  Elyse O Kharbanda; Gabriela Vazquez-Benitez; Heather S Lipkind; Sangini S Sheth; Jingyi Zhu; Allison L Naleway; Nicola P Klein; Rulin Hechter; Matthew F Daley; James G Donahue; Michael L Jackson; Alison Tse Kawai; Lakshmi Sukumaran; James D Nordin
Journal:  Obstet Gynecol       Date:  2018-07       Impact factor: 7.661

2.  The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.

Authors: 
Journal:  Public Health Rep       Date:  2015 Jan-Feb       Impact factor: 2.792

3.  Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine.

Authors:  Lina S Sy; Kristin I Meyer; Nicola P Klein; Chun Chao; Christine Velicer; T Craig Cheetham; Bradley K Ackerson; Jeff M Slezak; Harpreet S Takhar; John Hansen; Kamala Deosaransingh; Kai-Li Liaw; Steven J Jacobsen
Journal:  Hum Vaccin Immunother       Date:  2017-12-14       Impact factor: 3.452

4.  Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants.

Authors:  Elizabeth C Ailes; Regina M Simeone; April L Dawson; Emily E Petersen; Suzanne M Gilboa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-11

5.  The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States.

Authors:  Pedro L Moro; Michael M McNeil; Lakshmi Sukumaran; Karen R Broder
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

6.  Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.

Authors:  Sarah C MacDonald; Jacqueline M Cohen; Alice Panchaud; Thomas F McElrath; Krista F Huybrechts; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-07-22       Impact factor: 2.890

7.  Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.

Authors:  Holly C Groom; Ning Smith; Stephanie A Irving; Padma Koppolu; Gabriela Vazquez-Benitez; Elyse O Kharbanda; Matthew F Daley; James G Donahue; Darios Getahun; Lisa A Jackson; Nicola P Klein; Natalie L McCarthy; James D Nordin; Lakshmi Panagiotakopoulos; Allison L Naleway
Journal:  Vaccine       Date:  2019-09-20       Impact factor: 3.641

8.  Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies.

Authors:  Gabriela Vazquez-Benitez; Elyse O Kharbanda; Allison L Naleway; Heather Lipkind; Lakshmi Sukumaran; Natalie L McCarthy; Saad B Omer; Lei Qian; Stanley Xu; Michael L Jackson; Vinutha Vijayadev; Nicola P Klein; James D Nordin
Journal:  Am J Epidemiol       Date:  2016-07-22       Impact factor: 4.897

9.  Adverse Outcomes in Pregnant Women Hospitalized With Respiratory Syncytial Virus Infection: A Case Series.

Authors:  Anne M Hause; Lakshmi Panagiotakopoulos; Eric S Weintraub; Lina S Sy; Sungching C Glenn; Hung-Fu Tseng; Michael M McNeil
Journal:  Clin Infect Dis       Date:  2021-01-23       Impact factor: 9.079

10.  Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011.

Authors:  Allison L Naleway; Brad Crane; Ning Smith; Matthew F Daley; James Donahue; Julianne Gee; Sharon K Greene; Theresa Harrington; Lisa A Jackson; Nicola P Klein; Hung Fu Tseng; Claudia Vellozzi; Eric S Weintraub
Journal:  Vaccine       Date:  2015-11-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.